Below is our recent interview with Jonathan Scheiman, Co-Founder & CEO at FitBiomics:
Q: Could you provide our readers with a brief introduction to your company?
A: Our mission is to empower, educate, and elevate. We’re working to inspire and build a world where greatness is possible for everyone by driving transformation from the inside out to maximize human potential. FitBiomics is simultaneously bridging the gap between sports and science, bringing communities together, and inspiring the next generation of scientists. The new frontier of human health & wellness is Nella — a daily capsule of next-gen performance probiotics designed to help anyone pursuing a healthy and active lifestyle to a new frontier of personal best, from the inside out. Nella gives you the guts to defy your limits.
Q: Any highlights on your recent announcement?
A: With a new subscription price of $59, our daily capsule, Nella, is now easier than ever to add into a daily routine and positively impact health and wellness resolutions for 2022. The one-time purchase price remains at the current price of $75.
Q: Can you give us more insights into your offering?
A: The product is manufactured using probiotics sourced from the microbiome of elite endurance athletes. FitBiomics supports that the source of the probiotic strains matters when it comes to athletic performance. The American-made, gluten free, vegan probiotic is certified by Informed Sport, a service which identifies banned substances.
The Nella probiotic supplement is trusted by elite competitors across the country, including Olympic medalists, professional athletes, and USA record holders. Additionally, FitBiomics is in partnership with and serves as the official probiotic of Fordham University Athletics and St. John’s University Athletics.
Q: What can we expect from your company in the next 6 months? What are your plans?
A: We have a lot planned as far as partnerships as well as new products in the pipeline. I can sum up the latter in one word: Veillonella. Yes, the lactic acid eating probiotic that improves endurance and was published in Nature Medicine is in the commercial queue…so stay tuned.
Q: What’s something about your company that people might not know about?
A: At our heart, we are a biotechnology company focused on continued microbiome R&D. We’re expanding our discovery platform for continued decoding of elite phenotypes to develop additional next-generation probiotics. Our mission is to improve human health and performance, holistically, across multiple functional applications.